Company intelligence / Profile preview

Velasco

Ownership: Private
Development stage: Other

Overview

Velasco is an early-stage biotechnology company focused on developing novel therapeutic approaches for the treatment of cancer and inflammatory diseases. The company operates primarily in a stealth or semi-stealth capacity, leveraging proprietary insights into disease biology to identify and validate new drug targets. Velasco's current efforts are centered on pre-clinical research and the optimization of small molecule candidates. The company aims to address significant unmet medical needs by targeting pathways that are currently difficult to modulate with existing therapies.

Therapeutic areas: OncologyImmunology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Velasco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Velasco.

Explore the full profile